Table 1.
Author | Publication Date | Device | Type of Devices | Subject Study | Duration | Method | Results |
---|---|---|---|---|---|---|---|
Petrovic et al. | 2012 | Respifit | Threshold | 20 COPD | 8 weeks | Direct by cardiopulmonary and stress test | Enhances inspiratory muscle function, dyspnea, and quality of life. |
Magadle et al. | 2007 | PowerBreathe® | Resistive load and | 34 COPD | 12 weeks | 6MWT, SGRQ | Enhances inspiratory muscle function and dyspnea perception. |
Tounsi et al. | 2021 | PowerBreathe® | Resistive load and | 32 COPD | 8 weeks | BBS, ABC, 6MWT | Enhances inspiratory muscle function and functional balance according to BBS and ABC. |
Charususin et al. | 2018 | PowerBreathe® | Resistive load and | 219 COPD | 5–8 weeks | 6MWT. | No differences in 6MWT. Gains in respiratory muscle function and also endurance exercise capacity. |
Langer et al. | 2018 | PowerBreathe® | Resistive load and | 20 COPD | 8 weeks | PImax, T.lim | Improvments in Pi,max and T,lim. Telemonitorization. |
Beaumont et al. | 2015 | Threshold IMT® | Threshold | 23 COPD | 3 weeks | Borg scale, 6MWT, PImax. Cycle ergometer |
Subgroup of patients with FEV1 < 50% pred., dyspnea was significantly improved. |
McCreery et al. | 2021 | PrO2 Fit | Resistive load | 10 BQ | 8 weeks | VO2, VCO2 and pulmonary function (FVC, FEV1) | Increased inspiratory muscle strength and endurance. Telemonitorization. |
Formiga et al. | 2018 | PrO2 Fit | Resistive load | 81 COPD | 1 day | FEV1, FVC, 6MWT, MIP, ID, SMIP. | Increased inspiratory muscle strength and endurance |
Formiga et al. | 2020 | PrO2 Fit | Resistive load | On going | 8 weeks | mMRC, FEV1, FVC, 6MWT. | Test of incremental respiratory endurance training method has the potential to provide additional clinical benefits in COPD. |
Daynes et al. | 2018 | Aerosure Medic® | Resistive load | 23 COPD | 8 weeks | mMRC, PImax, PEmax. ISWT, ESWT | Improvmente PI max, PE max, and reducing dyspnoea. |
Stavrou et al. | 2021 | AeroFit IMT® MicroRPM |
Resistive load | 21 athletes | 1 day | PSQI, pulmonary function test, ergospirometry | Compare both not differences between devices. AirOFitPRO™ is easier to operate as a device and provides more information. |
Bernardi et al. | 2015 | SpiroTiger® | Resistive load | 20 COPD | 4 weeks | Spirometry 6MWT, VO2max, SGRQ | Increased inspiratory muscle and quality of life. |
Włodarczyk et al. | 2015 | SpiroTiger® | Voluntary isocapnic hyperpnea | - | - | 6MWT | Improve quality of life and distance in 6MWT |
Gonzalez-Montesinos et al. | 2020 | FeelBreathe® | Nasal restriction | 18 COPD | 8 weeks | PI max y VO2max | Positive effects in dynamic hyperinflation, breathing pattern, and breathing efficiency, with higher expiratory and inspiratory time. |
Arnedillo et al. | 2020 | FeelBreathe® | Nasal restriction | 16 COPD | 8 weeks | Inspiratory muscle strength (PImax), dyspnea (mMRC), quality of life (CAT) and exercise capacity (6MWT) |
Improvements in quality of life, dyspnea, exercise capacity, and inspiratory muscle strength |
Gonzalez-Montesinos et al. | 2021 | FeelBreathe® | Nasal restriction | 20 COPD | 8 weeks | VO2, VCO2, respiratory rate | FB added to a pulmonary rehabilitation program in COPD patients could improve tolerance in the incremental exercise test and energy efficiency |
COPD: Chronic Obstructive Pulmonary Disease. SGRQ: St. George Respiratory Questionnaire score. BBS: Berg Balance Scale. ABC: activity specific Balance Confidence scale. 6MWT: 6 min walking test. PImax: maximal inspiratory mouth pressure. T,lim: endurance capacity of inspiratory muscles. BQ: Bronchiectasis. FEV1: forced expiratory volume in the first second. FVC: forced vital capacity. PImax: maximal inspiratory pressure, PEmax: maximal expiratory pressure. ID: inspiratory duration. SMIP: sustained maximal inspiratory pressure. mMRC: modified Medical Research Council. ISWT: incremental shuttle walk test. ESWT: endurance shuttle walk test. PSQI: Pittsburgh Sleep Quality Index. RR: respiratory rate, VO2: oxygen consumption, VCO2: carbon dioxide production. FB: FeelBreathe®.